Volume 62, Supplement 1, 2022-3-1, Pages S1-S83

Articles in this issue:

1. Title Page

2. Customizing early breast cancer therapies – The 2021 St. Gallen International Breast Cancer Consensus Conference

3. Global challenges in breast cancer detection and treatment

4. Breast and axillary surgery after neoadjuvant systemic treatment – A review of clinical routine recommendations and the latest clinical research

5. Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer

6. Neoadjuvant approach in patients with early breast cancer: patient assessment, staging, and planning

7. Pathology after neoadjuvant treatment – How to assess residual disease

8. Immune checkpoint inhibition in the treatment of early stage triple negative breast cancer: 2021 update

9. Development of novel agents for the treatment of early estrogen receptor positive breast cancer

10. De-escalating axillary surgery in early-stage breast cancer

11. Axillary surgery in node-positive breast cancer

12. Accelerating progress in early triple-negative breast cancer: A viewpoint on antibody-drug conjugates, back from St Gallen breast cancer conference 2021

13. Locally advanced breast cancer

14. Surgery and prophylactic surgery in hereditary breast cancer

15. Unmet challenges in systemic therapy for early stage breast cancer

16. Integrating CDK4/6 inhibitors in the treatment of patients with early breast cancer

17. Accelerating progress to innovation for patients: Trial design and risk stratification